Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.

Rodrigues M, Mobuchon L, Houy A, Fiévet A, Gardrat S, Barnhill RL, Popova T, Servois V, Rampanou A, Mouton A, Dayot S, Raynal V, Galut M, Putterman M, Tick S, Cassoux N, Roman-Roman S, Bidard FC, Lantz O, Mariani P, Piperno-Neumann S, Stern MH.

Nat Commun. 2018 May 14;9(1):1866. doi: 10.1038/s41467-018-04322-5.

2.

Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.

Renault AL, Mebirouk N, Fuhrmann L, Bataillon G, Cavaciuti E, Le Gal D, Girard E, Popova T, La Rosa P, Beauvallet J, Eon-Marchais S, Dondon MG, d'Enghien CD, Laugé A, Chemlali W, Raynal V, Labbé M, Bièche I, Baulande S, Bay JO, Berthet P, Caron O, Buecher B, Faivre L, Fresnay M, Gauthier-Villars M, Gesta P, Janin N, Lejeune S, Maugard C, Moutton S, Venat-Bouvet L, Zattara H, Fricker JP, Gladieff L, Coupier I; CoF-AT; GENESIS; kConFab, Chenevix-Trench G, Hall J, Vincent-Salomon A, Stoppa-Lyonnet D, Andrieu N, Lesueur F.

Breast Cancer Res. 2018 Apr 17;20(1):28. doi: 10.1186/s13058-018-0951-9.

3.

Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis.

Lopez-Delisle L, Pierre-Eugène C, Louis-Brennetot C, Surdez D, Raynal V, Baulande S, Boeva V, Grossetête-Lalami S, Combaret V, Peuchmaur M, Delattre O, Janoueix-Lerosey I.

Oncogene. 2018 Mar;37(11):1417-1429. doi: 10.1038/s41388-017-0039-5. Epub 2018 Jan 11.

PMID:
29321660
4.

Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.

Boeva V, Louis-Brennetot C, Peltier A, Durand S, Pierre-Eugène C, Raynal V, Etchevers HC, Thomas S, Lermine A, Daudigeos-Dubus E, Geoerger B, Orth MF, Grünewald TGP, Diaz E, Ducos B, Surdez D, Carcaboso AM, Medvedeva I, Deller T, Combaret V, Lapouble E, Pierron G, Grossetête-Lalami S, Baulande S, Schleiermacher G, Barillot E, Rohrer H, Delattre O, Janoueix-Lerosey I.

Nat Genet. 2017 Sep;49(9):1408-1413. doi: 10.1038/ng.3921. Epub 2017 Jul 24.

PMID:
28740262
5.

Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications.

Popova T, Manié E, Boeva V, Battistella A, Goundiam O, Smith NK, Mueller CR, Raynal V, Mariani O, Sastre-Garau X, Stern MH.

Cancer Res. 2016 Apr 1;76(7):1882-91. doi: 10.1158/0008-5472.CAN-15-2128. Epub 2016 Jan 19.

6.

Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.

Grünewald TG, Bernard V, Gilardi-Hebenstreit P, Raynal V, Surdez D, Aynaud MM, Mirabeau O, Cidre-Aranaz F, Tirode F, Zaidi S, Perot G, Jonker AH, Lucchesi C, Le Deley MC, Oberlin O, Marec-Bérard P, Véron AS, Reynaud S, Lapouble E, Boeva V, Rio Frio T, Alonso J, Bhatia S, Pierron G, Cancel-Tassin G, Cussenot O, Cox DG, Morton LM, Machiela MJ, Chanock SJ, Charnay P, Delattre O.

Nat Genet. 2015 Sep;47(9):1073-8. doi: 10.1038/ng.3363. Epub 2015 Jul 27.

7.

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.

Madic J, Kiialainen A, Bidard FC, Birzele F, Ramey G, Leroy Q, Rio Frio T, Vaucher I, Raynal V, Bernard V, Lermine A, Clausen I, Giroud N, Schmucki R, Milder M, Horn C, Spleiss O, Lantz O, Stern MH, Pierga JY, Weisser M, Lebofsky R.

Int J Cancer. 2015 May 1;136(9):2158-65. doi: 10.1002/ijc.29265. Epub 2014 Oct 23.

8.

Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.

Gruel N, Benhamo V, Bhalshankar J, Popova T, Fréneaux P, Arnould L, Mariani O, Stern MH, Raynal V, Sastre-Garau X, Rouzier R, Delattre O, Vincent-Salomon A.

Breast Cancer Res. 2014 May 8;16(3):R46. doi: 10.1186/bcr3653.

9.

A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation.

Mahmood SF, Gruel N, Chapeaublanc E, Lescure A, Jones T, Reyal F, Vincent-Salomon A, Raynal V, Pierron G, Perez F, Camonis J, Del Nery E, Delattre O, Radvanyi F, Bernard-Pierrot I.

Carcinogenesis. 2014 Mar;35(3):670-82. doi: 10.1093/carcin/bgt351. Epub 2013 Oct 22.

PMID:
24148822
10.

Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis.

Boeva V, Jouannet S, Daveau R, Combaret V, Pierre-Eugène C, Cazes A, Louis-Brennetot C, Schleiermacher G, Ferrand S, Pierron G, Lermine A, Rio Frio T, Raynal V, Vassal G, Barillot E, Delattre O, Janoueix-Lerosey I.

PLoS One. 2013 Aug 26;8(8):e72182. doi: 10.1371/journal.pone.0072182. eCollection 2013.

11.

Germline BAP1 mutations predispose to renal cell carcinomas.

Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d'Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A, Sastre-Garau X, Desjardins L, Gyapay G, Raynal V, Sinilnikova OM, Andrieu N, Manié E, de Pauw A, Gesta P, Bonadona V, Maugard CM, Penet C, Avril MF, Barillot E, Cabaret O, Delattre O, Richard S, Caron O, Benfodda M, Hu HH, Soufir N, Bressac-de Paillerets B, Stoppa-Lyonnet D, Stern MH.

Am J Hum Genet. 2013 Jun 6;92(6):974-80. doi: 10.1016/j.ajhg.2013.04.012. Epub 2013 May 16.

12.

The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking.

Mazot P, Cazes A, Boutterin MC, Figueiredo A, Raynal V, Combaret V, Hallberg B, Palmer RH, Delattre O, Janoueix-Lerosey I, Vigny M.

Oncogene. 2011 Apr 28;30(17):2017-25. doi: 10.1038/onc.2010.595. Epub 2011 Jan 17.

PMID:
21242967
13.

A prognostic DNA signature for T1T2 node-negative breast cancer patients.

Gravier E, Pierron G, Vincent-Salomon A, Gruel N, Raynal V, Savignoni A, De Rycke Y, Pierga JY, Lucchesi C, Reyal F, Fourquet A, Roman-Roman S, Radvanyi F, Sastre-Garau X, Asselain B, Delattre O.

Genes Chromosomes Cancer. 2010 Dec;49(12):1125-34. doi: 10.1002/gcc.20820.

PMID:
20842727
14.

Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma.

Gruel N, Lucchesi C, Raynal V, Rodrigues MJ, Pierron G, Goudefroye R, Cottu P, Reyal F, Sastre-Garau X, Fourquet A, Delattre O, Vincent-Salomon A.

Eur J Cancer. 2010 Sep;46(13):2399-407. doi: 10.1016/j.ejca.2010.05.013. Epub 2010 Jun 21.

PMID:
20570624
15.

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.

Janoueix-Lerosey I, Lequin D, Brugières L, Ribeiro A, de Pontual L, Combaret V, Raynal V, Puisieux A, Schleiermacher G, Pierron G, Valteau-Couanet D, Frebourg T, Michon J, Lyonnet S, Amiel J, Delattre O.

Nature. 2008 Oct 16;455(7215):967-70. doi: 10.1038/nature07398.

PMID:
18923523
16.

Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.

Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, Vallot C, Pierron G, Radvanyi F, Delattre O.

Cancer Res. 2008 Sep 1;68(17):7165-75. doi: 10.1158/0008-5472.CAN-08-1360.

17.

ESR1 gene amplification in breast cancer: a common phenomenon?

Vincent-Salomon A, Raynal V, Lucchesi C, Gruel N, Delattre O.

Nat Genet. 2008 Jul;40(7):809; author reply 810-2. doi: 10.1038/ng0708-809a. No abstract available.

PMID:
18583967
18.

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.

Vincent-Salomon A, Lucchesi C, Gruel N, Raynal V, Pierron G, Goudefroye R, Reyal F, Radvanyi F, Salmon R, Thiery JP, Sastre-Garau X, Sigal-Zafrani B, Fourquet A, Delattre O; breast cancer study group of the Institut Curie.

Clin Cancer Res. 2008 Apr 1;14(7):1956-65. doi: 10.1158/1078-0432.CCR-07-1465.

19.

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.

Idbaih A, Marie Y, Lucchesi C, Pierron G, Manié E, Raynal V, Mosseri V, Hoang-Xuan K, Kujas M, Brito I, Mokhtari K, Sanson M, Barillot E, Aurias A, Delattre JY, Delattre O.

Int J Cancer. 2008 Apr 15;122(8):1778-86.

20.

X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.

Vincent-Salomon A, Ganem-Elbaz C, Manié E, Raynal V, Sastre-Garau X, Stoppa-Lyonnet D, Stern MH, Heard E.

Cancer Res. 2007 Jun 1;67(11):5134-40.

21.

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.

Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B, Longy M, Raynal V, Pierron G, de Mascarel I, Taris C, Stoppa-Lyonnet D, Pierga JY, Salmon R, Sastre-Garau X, Fourquet A, Delattre O, de Cremoux P, Aurias A.

Breast Cancer Res. 2007;9(2):R24.

22.

VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles.

La Rosa P, Viara E, Hupé P, Pierron G, Liva S, Neuvial P, Brito I, Lair S, Servant N, Robine N, Manié E, Brennetot C, Janoueix-Lerosey I, Raynal V, Gruel N, Rouveirol C, Stransky N, Stern MH, Delattre O, Aurias A, Radvanyi F, Barillot E.

Bioinformatics. 2006 Sep 1;22(17):2066-73. Epub 2006 Jul 4.

PMID:
16820431
23.

Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.

Schleiermacher G, Bourdeaut F, Combaret V, Picrron G, Raynal V, Aurias A, Ribeiro A, Janoueix-Lerosey I, Delattre O.

Oncogene. 2005 May 5;24(20):3377-84.

PMID:
15735707
24.

Variety and complexity of chromosome 17 translocations in neuroblastoma.

Schleiermacher G, Raynal V, Janoueix-Lerosey I, Combaret V, Aurias A, Delattre O.

Genes Chromosomes Cancer. 2004 Feb;39(2):143-50.

PMID:
14695994
25.

Phylogeographical variation of chloroplast DNA in holm oak (Quercus ilex L.).

Lumaret R, Mir C, Michaud H, Raynal V.

Mol Ecol. 2002 Nov;11(11):2327-36.

PMID:
12406243
26.

Cell-surface expression of RhD blood group polypeptide is posttranscriptionally regulated by the RhAG glycoprotein.

Mouro-Chanteloup I, D'Ambrosio AM, Gane P, Le Van Kim C, Raynal V, Dhermy D, Cartron JP, Colin Y.

Blood. 2002 Aug 1;100(3):1038-47.

27.

The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast.

Marini AM, Matassi G, Raynal V, André B, Cartron JP, Chérif-Zahar B.

Nat Genet. 2000 Nov;26(3):341-4.

PMID:
11062476
28.

The members of the RH gene family (RH50 and RH30) followed different evolutionary pathways.

Matassi G, Chérif-Zahar B, Pesole G, Raynal V, Cartron JP.

J Mol Evol. 1999 Feb;48(2):151-9.

PMID:
9929383
29.

Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia.

Chérif-Zahar B, Bony V, Steffensen R, Gane P, Raynal V, Goosens D, Laursen JS, Varming K, Jersild C, Cartron JP.

Br J Haematol. 1998 Sep;102(5):1263-70.

PMID:
9753055
30.

Rh-deficiency of the regulator type caused by splicing mutations in the human RH50 gene.

Chérif-Zahar B, Matassi G, Raynal V, Gane P, Delaunay J, Arrizabalaga B, Cartron JP.

Blood. 1998 Oct 1;92(7):2535-40.

31.

Molecular defects of the RHCE gene in Rh-deficient individuals of the amorph type.

Chérif-Zahar B, Matassi G, Raynal V, Gane P, Mempel W, Perez C, Cartron JP.

Blood. 1998 Jul 15;92(2):639-46.

32.

A novel single missense mutation identified along the RH50 gene in a composite heterozygous Rhnull blood donor of the regulator type.

Hyland CA, Chérif-Zahar B, Cowley N, Raynal V, Parkes J, Saul A, Cartron JP.

Blood. 1998 Feb 15;91(4):1458-63.

33.

Organization of the human RH50A gene (RHAG) and evolution of base composition of the RH gene family.

Matassi G, Chérif-Zahar B, Raynal V, Rouger P, Cartron JP.

Genomics. 1998 Jan 15;47(2):286-93.

PMID:
9479501
34.

RH gene structure: reassignment of two exon-exon junctions.

Cherif-Zahar B, Raynal V, Cartron JP.

Blood. 1997 Jun 15;89(12):4661-2. No abstract available.

35.

Lack of RHCE-encoded proteins in the D--phenotype may result from homologous recombination between the two RH genes.

Cherif-Zahar B, Raynal V, Cartron JP.

Blood. 1996 Aug 15;88(4):1518-20. No abstract available.

36.

Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency.

Cherif-Zahar B, Raynal V, Gane P, Mattei MG, Bailly P, Gibbs B, Colin Y, Cartron JP.

Nat Genet. 1996 Feb;12(2):168-73.

PMID:
8563755
37.

Molecular analysis of the structure and expression of the RH locus in individuals with D--, Dc-, and DCw- gene complexes.

Chérif-Zahar B, Raynal V, D'Ambrosio AM, Cartron JP, Colin Y.

Blood. 1994 Dec 15;84(12):4354-60.

38.

Organization of the gene (RHCE) encoding the human blood group RhCcEe antigens and characterization of the promoter region.

Chérif-Zahar B, Le Van Kim C, Rouillac C, Raynal V, Cartron JP, Colin Y.

Genomics. 1994 Jan 1;19(1):68-74.

PMID:
8188244
39.

Structure and expression of the RH locus in the Rh-deficiency syndrome.

Chérif-Zahar B, Raynal V, Le Van Kim C, D'Ambrosio AM, Bailly P, Cartron JP, Colin Y.

Blood. 1993 Jul 15;82(2):656-62.

40.

Molecular cloning and primary structure of the human blood group RhD polypeptide.

Le van Kim C, Mouro I, Chérif-Zahar B, Raynal V, Cherrier C, Cartron JP, Colin Y.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10925-9.

41.

Multiple Rh messenger RNA isoforms are produced by alternative splicing.

Le Van Kim C, Chérif-Zahar B, Raynal V, Mouro I, Lopez M, Cartron JP, Colin Y.

Blood. 1992 Aug 15;80(4):1074-8.

42.

Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis.

Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP.

Blood. 1991 Nov 15;78(10):2747-52.

Supplemental Content

Loading ...
Support Center